LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL VIRAL TRANSPORT MEDIUM MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 INCREASING DEMAND FOR VTM DUE TO SURGE IN COVID-19 INFECTION
EXHIBIT 4 IMPACT OF LAUNCHES OF NEW PRODUCTS AND ENTRY OF NEW MARKET PLAYERS
EXHIBIT 5 IMPACT OF INCREASING PREVALENCE OF INFECTIOUS DISEASES
EXHIBIT 6 IMPACT OF SURGE IN COVID-19 INFECTIONS
EXHIBIT 7 DAILY CORONAVIRUS CASES 2020-2022 (MILLION)
EXHIBIT 8 COVID-19 TEST PER MILLION CASES IN FEB 2022
EXHIBIT 9 IMPACT OF INCREASE IN DIAGNOSIS RATES FOR VIRAL INFECTIOUS DISEASES
EXHIBIT 10 IMPACT OF VTM SPECIMENS POSE HIGHER BIOHAZARD DURING TRANSPORTATION THAN OTHER SOLUTIONS
EXHIBIT 11 IMPACT OF FALSE-NEGATIVE RESULTS IN BORDERLINE CASES
EXHIBIT 12 VIRAL TRANSPORT MEDIA: FACTORS AFFECTING NEGATIVE/ FALSE RESULT
EXHIBIT 13 IMPACT OF LACK OF ACCESS TO DIAGNOSIS SERVICES IN LMICS
EXHIBIT 14 GLOBAL VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 15 FIVE FORCES ANALYSIS 2021
EXHIBIT 16 INCREMENTAL GROWTH BY PRODUCTS 2021 & 2027
EXHIBIT 17 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY PRODUCTS 2022-2027
EXHIBIT 18 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY PRODUCTS: INCREMENTAL GROWTH
EXHIBIT 19 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY PRODUCTS: ABSOLUTE GROWTH
EXHIBIT 20 GLOBAL VIRAL TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 21 GLOBAL VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 22 GLOBAL UNIVERSAL TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 23 GLOBAL UNIVERSAL TRANSPORT MEDIA MARKET 2021–2027 ($ MILLION)
EXHIBIT 24 GLOBAL TREND IN CASE NOTIFICATION OF PEOPLE NEWLY DIAGNOSED WITH TB 2016-2020 (PER YEAR IN MILLION)
EXHIBIT 25 GLOBAL MOLECULAR TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 26 GLOBAL MOLECULAR TRANSPORT MEDIA MARKET 2021–2027 ($ MILLION)
EXHIBIT 27 INCREMENTAL GROWTH BY USAGE 2021 & 2027
EXHIBIT 28 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY USES 2022-2027
EXHIBIT 29 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY USAGE: INCREMENTAL GROWTH
EXHIBIT 30 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY USAGE: ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL DIAGNOSIS VIRAL TRANSPORT MEDIUM MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 32 GLOBAL PREVALENCE OF STI VIRAL DISEASES 2020 (MILLION)
EXHIBIT 33 GLOBAL DIAGNOSIS USAGE MARKET 2021–2027 ($ MILLION)
EXHIBIT 34 GLOBAL PRE-CLINICAL TESTING MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 35 GLOBAL PRE-CLINICAL TESTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 36 INCREMENTAL GROWTH BY PRODUCTS 2021 & 2027
EXHIBIT 37 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2022-2027
EXHIBIT 38 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY INDICATION: INCREMENTAL GROWTH
EXHIBIT 39 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY INDICATION: ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL INFLUENZA & COVID-19 MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL INFLUENZA & COVID-19 INDICATION MARKET 2021–2027 ($ MILLION)
EXHIBIT 43 GLOBAL HERPES SIMPLEX VIRUS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL HERPES SIMPLEX VIRUS INDICATION MARKET 2021–2027 ($ MILLION)
EXHIBIT 45 GLOBAL RESPIRATORY SYNCYTIAL VIRUS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL RESPIRATORY SYNCYTIAL VIRUS MARKET 2021–2027 ($ MILLION)
EXHIBIT 47 GLOBAL VARICELLA-ZOSTER VIRUS MARKET 2021–2027 ($ MILLION)
EXHIBIT 48 GLOBAL VARICELLA ZOSTER VIRUS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL OTHERS INDICATION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 50 GLOBAL OTHER VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 51 INCREMENTAL GROWTH BY END-USER 2021 C& 2027
EXHIBIT 52 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2022-2027
EXHIBIT 53 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 54 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL LABS VIRAL TRANSPORT MEDIUM MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL LABS VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 57 GLOBAL HOSPITALS & CLINICS VIRAL TRANSPORT MEDIUM MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL HOSPITALS & CLINICS VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 59 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY OTHER END-USERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL OTHERS VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 61 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 62 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY GEOGRAPHY 2022-2027
EXHIBIT 63 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 64 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 65 VIRAL TRANSPORT MEDIUM MARKET NORTH AMERICA: KEY COUNTRIES 2019 ($ MILLION)
EXHIBIT 66 NORTH AMERICA VIRAL TRANSPORT MEDIUM MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 67 NORTH AMERICA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 68 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 69 US VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 70 CANADA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 71 VIRAL TRANSPORT MEDIUM MARKET EUROPE: KEY COUNTRIES 2019 ($ MILLION)
EXHIBIT 72 EUROPE VIRAL TRANSPORT MEDIUM MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 EUROPE VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 74 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 75 UK: VARICELLA AGE-SPECIFIC ANNUAL COMMUNITY INCIDENTS PER 100,000
EXHIBIT 76 UK VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 77 FRANCE: AGE-SPECIFIC ANNUAL COMMUNITY INCIDENCE OF VARICELLA PER 100,000
EXHIBIT 78 FRANCE VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 79 ITALY: INCIDENCE OF HERPES BY AGE GROUP & GENDER
EXHIBIT 80 ITALY VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 81 GERMANY: TOTAL COVID-19 CASES AUG 2021–FEB 2022 (MILLION)
EXHIBIT 82 GERMANY VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 83 SPAIN VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 84 VIRAL TRANSPORT MEDIUM MARKET APAC: KEY COUNTRIES 2019 ($ MILLION)
EXHIBIT 85 APAC VIRAL TRANSPORT MEDIUM MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 86 APAC VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 87 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 88 CHINA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 89 JAPAN VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 90 INDIA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 91 AGE STANDARDIZED HOSPITALIZATION RATE NOTIFIABLE COMMUNICATION DISEASES 2013–2017
EXHIBIT 92 AUSTRALIA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 93 SOUTH KOREA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 94 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET: KEY COUNTRIES 2019 ($ MILLION)
EXHIBIT 95 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 96 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 97 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 98 PREVALENCE OF HERPES ZOSTER IN BRAZIL (VIA REGION) 2021
EXHIBIT 99 BRAZIL VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 100 MEXICO VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 101 ARGENTINA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 102 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET: KEY COUNTRIES 2019 ($ MILLION)
EXHIBIT 103 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 104 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 105 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 106 TURKEY: INCIDENT RATE OF HERPES ZOSTER WITH RESPECT TO AGE (2011–2019) (PER 100,000 PEOPLE)
EXHIBIT 107 TURKEY VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 108 SAUDI ARABIA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 109 SOUTH AFRICA VIRAL TRANSPORT MEDIUM MARKET 2021–2027 ($ MILLION)
EXHIBIT 110 THERMO FISHER SCIENTIFIC: ANNUAL REVENUE 2018–2020 ($ BILLION)
EXHIBIT 111 THERMO FISHER SCIENTIFIC ANNUAL REVENUE BY SEGMENT 2020 (%)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 SOME OF COVID-19 TRANSPORT MEDIA MANUFACTURER AND PRODUCTS
TABLE 4 COVID-19 TEST DONE DURING 2020-2022
TABLE 5 VIRAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 6 VIRAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 7 UNIVERSAL TRANSPORT MEDIA KIT & MANUFACTURER
TABLE 8 UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 9 UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 10 MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 11 MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 12 OVERALL COVID-19 DIAGNOSIS TEST BY REGION IN 2022
TABLE 13 VIRAL TRANSPORT MEDIUM DIAGNOSIS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 14 VIRAL TRANSPORT MEDIUM DIAGNOSIS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 15 VIRAL TRANSPORT MEDIUM PRE-CLINICAL TESTING MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 16 VIRAL TRANSPORT MEDIUM PRE-CLINICAL TESTING MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 17 VIRAL TRANSPORT MEDIUM INFLUENZA & COVID-19 MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 18 VIRAL TRANSPORT MEDIUM INFLUENZA & COVID-19 MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 19 VIRAL TRANSPORT MEDIUM HERPES SIMPLEX VIRUS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 20 VIRAL TRANSPORT MEDIUM HERPES SIMPLEX VIRUS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 21 VIRAL TRANSPORT MEDIUM RESPIRATORY SYNCYTIAL VIRUS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 22 VIRAL TRANSPORT MEDIUM RESPIRATORY SYNCYTIAL VIRUS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 23 VIRAL TRANSPORT MEDIUM VARICELLA-ZOSTER VIRUS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 24 VIRAL TRANSPORT MEDIUM VARICELLA ZOSTER VIRUS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 25 OTHER VIRAL TRANSPORT MEDIUM MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 26 OTHER VIRAL TRANSPORT MEDIUM MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 27 LABS VIRAL TRANSPORT MEDIUM KITS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 28 LABS VIRAL TRANSPORT MEDIUM KITS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 29 HOSPITALS & CLINICS VIRAL TRANSPORT MEDIUM KITS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 30 HOSPITALS & CLINICS VIRAL TRANSPORT MEDIUM KITS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 31 OTHER VIRAL TRANSPORT MEDIUM KITS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 32 OTHER VIRAL TRANSPORT MEDIUM KITS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 33 NORTH AMERICA VIRAL TRANSPORT MEDIUM MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 34 NORTH AMERICA VIRAL TRANSPORT MEDIUM MARKET BY PRODUCT 2021−2027 (%)
TABLE 35 NORTH AMERICA VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 ($ MILLION)
TABLE 36 NORTH AMERICA VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 (%)
TABLE 37 NORTH AMERICA VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 ($ MILLION)
TABLE 38 NORTH AMERICA VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 (%)
TABLE 39 NORTH AMERICA VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 40 NORTH AMERICA VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 (%)
TABLE 41 US: MEDICAL DIAGNOSTICS LABS
TABLE 42 EUROPE VIRAL TRANSPORT MEDIUM MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 43 EUROPE VIRAL TRANSPORT MEDIUM MARKET BY PRODUCT 2021−2027 (%)
TABLE 44 EUROPE VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 ($ MILLION)
TABLE 45 EUROPE VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 (%)
TABLE 46 EUROPE VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 ($ MILLION)
TABLE 47 EUROPE VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 (%)
TABLE 48 EUROPE VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 49 EUROPE VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 (%)
TABLE 50 APAC VIRAL TRANSPORT MEDIUM MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 51 APAC VIRAL TRANSPORT MEDIUM MARKET BY PRODUCT 2021−2027 (%)
TABLE 52 APAC VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 ($ MILLION)
TABLE 53 APAC VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 (%)
TABLE 54 APAC VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 ($ MILLION)
TABLE 55 APAC VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 (%)
TABLE 56 APAC VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 57 APAC VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 (%)
TABLE 58 CHINA: LABORATORY DETECTION OF ILI SPECIMENS WEEK 15 IN 2019.
TABLE 59 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 60 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET BY PRODUCT 2021−2027 (%)
TABLE 61 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 ($ MILLION)
TABLE 62 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 (%)
TABLE 63 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 ($ MILLION)
TABLE 64 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 (%)
TABLE 65 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 66 LATIN AMERICA VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 (%)
TABLE 67 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET BY PRODUCTS 2021−2027 ($ MILLION)
TABLE 68 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET BY PRODUCTS 2021−2027 (%)
TABLE 69 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 ($ MILLION)
TABLE 70 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 (%)
TABLE 71 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 ($ MILLION)
TABLE 72 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 (%)
TABLE 73 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 ($ MILLION)
TABLE 74 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 (%)
TABLE 75 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 76 MIDDLE EAST & AFRICA VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 (%)
TABLE 77 BD: MAJOR PRODUCT OFFERINGS
TABLE 78 HARDY DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 79 HIMEDIA LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 80 LABORATORY CORPORATION OF AMERICA: MAJOR PRODUCT OFFERINGS
TABLE 81 PURITAN MEDICAL PRODUCTS: MAJOR PRODUCT OFFERINGS
TABLE 82 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 83 VIRCELL: MAJOR PRODUCT OFFERINGS
TABLE 84 AB MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 85 ACCUGENE USA: MAJOR PRODUCT OFFERINGS
TABLE 86 APICAL SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 87 AZOOKA LABS: MAJOR PRODUCT OFFERINGS
TABLE 88 BIOMED DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 89 BIOBOAVISTA: MAJOR PRODUCT OFFERINGS
TABLE 90 BIOGENEX LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 91 BIOLOGIX GROUP: MAJOR PRODUCT OFFERINGS
TABLE 92 BIOCOMMA: MAJOR PRODUCT OFFERINGS
TABLE 93 CHARM SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 94 CREATIVE LIFE SCIENCES CO. LTD.: MAJOR PRODUCT OFFERINGS
TABLE 95 CITOTEST LABWARE MANUFACTURING: MAJOR PRODUCT OFFERINGS
TABLE 96 CPT MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 97 COPAN DIAGNOSTIC INC.: MAJOR PRODUCT OFFERINGS
TABLE 98 DIASORIN MOLECULAR: MAJOR PRODUCT OFFERINGS
TABLE 99 EKF DIAGNOSTIC: MAJOR PRODUCT OFFERINGS
TABLE 100 ENSOL BIOSCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 101 GEMINI BIOPRODUCTS: MAJOR PRODUCT OFFERINGS
TABLE 102 GENERAL BIOLOGICS: MAJOR PRODUCT OFFERINGS
TABLE 103 GENTUERI: MAJOR PRODUCT OFFERINGS
TABLE 104 GENESIS LIFETECH MARKETING: MAJOR PRODUCT OFFERINGS
TABLE 105 HAN CHANG MEDIC: MAJOR PRODUCT OFFERINGS
TABLE 106 HEBEI CHAORAN MEDICAL INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 107 KSL DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 108 LUCENCE HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 109 LAUNCHWORKS: MAJOR PRODUCT OFFERINGS
TABLE 110 LIOFILCHEM: MAJOR PRODUCT OFFERINGS
TABLE 111 MEDICAL WIRE & EQUIPMENT: MAJOR PRODUCT OFFERINGS
TABLE 112 MIRACLEAN TECHNOLOGY (MANTACC): MAJOR PRODUCT OFFERINGS
TABLE 113 METADESIGN SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 114 MANILA HEALTHTEK: MAJOR PRODUCT OFFERINGS
TABLE 115 MATTEK: MAJOR PRODUCT OFFERINGS
TABLE 116 NODFORD INTERNATIONAL: MAJOR PRODUCT OFFERINGS
TABLE 117 STARPLEX SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 118 SANSURE BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 119 TITAN BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 120 VEGAS BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 121 ZYBIO: MAJOR PRODUCT OFFERINGS
TABLE 122 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 123 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 124 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 125 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY PRODUCT 2021−2027 (%)
TABLE 126 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 ($ MILLION)
TABLE 127 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY USAGE 2021−2027 (%)
TABLE 128 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 ($ MILLION)
TABLE 129 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY INDICATION 2021−2027 (%)
TABLE 130 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 131 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY END-USER 2021−2027 (%)
TABLE 132 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 133 GLOBAL VIRAL TRANSPORT MEDIUM MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 134 GLOBAL UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 135 GLOBAL UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 136 GLOBAL MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 137 GLOBAL MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 138 GLOBAL DIAGNOSIS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 139 GLOBAL DIAGNOSIS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 140 GLOBAL PRE-CLINICAL TESTING MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 141 GLOBAL PRE-CLINICAL TESTING MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 142 GLOBAL INFLUENZA & COVID-19 MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 143 GLOBAL INFLUENZA & COVID-19 MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 144 GLOBAL HERPES MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 145 GLOBAL HERPES MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 146 GLOBAL RESPIRATORY SYNCYTIAL VIRUS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 147 GLOBAL RESPIRATORY SYNCYTIAL VIRUS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 148 GLOBAL VARICELLA ZOSTER VIRUS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 149 GLOBAL VARICELLA ZOSTER VIRUS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 150 GLOBAL OTHER (INDICATIONS) MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 151 GLOBAL OTHER (INDICATIONS) MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 152 GLOBAL LABS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 153 GLOBAL LABS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 154 GLOBAL HOSPITALS & CLINICS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 155 GLOBAL HOSPITALS & CLINICS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 156 GLOBAL OTHER INDICATION MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 157 GLOBAL OTHER INDICATION MARKET BY GEOGRAPHY 2021−2027 (%)